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m-AAAEukaryotic cytochrome c oxidase (CcO), the terminal enzyme of the energy-transducing mitochondrial
electron transport chain is a hetero-oligomeric, heme–copper oxidase complex composed of both
mitochondrially and nuclear-encoded subunits. It is embedded in the inner mitochondrial membrane
where it couples the transfer of electrons from reduced cytochrome c to molecular oxygen with vectorial
proton translocation across the membrane. The biogenesis of CcO is a complicated sequential process that
requires numerous speciﬁc accessory proteins, so-called assembly factors, which include translational
activators, translocases, molecular chaperones, copper metallochaperones and heme a biosynthetic enzymes.
Besides these CcO-speciﬁc protein factors, the correct biogenesis of CcO requires an even greater number of
proteins with much broader substrate speciﬁcities. Indeed, growing evidence indicates that mitochondrial
ATP-dependent proteases might play an important role in CcO biogenesis. Out of the four identiﬁed energy-
dependent mitochondrial proteases, three were shown to be directly involved in proteolysis of CcO subunits.
In addition to their well-established protein-quality control function these oligomeric proteolytic complexes
with chaperone-like activities may function as molecular chaperones promoting productive folding and
assembly of subunit proteins. In this review, we summarize the current knowledge of the functional
involvement of eukaryotic CcO-speciﬁc assembly factors and highlight the possible signiﬁcance for CcO
biogenesis of mitochondrial ATP-dependent proteases.st Faculty of Medicine, Charles
lic.
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Mitochondria are highly dynamic semiautonomous organelles of
endosymbiotic, α-proteobacterial descent found in virtually all eukary-
otic cells. They harbor several essential metabolic pathways, produce
the bulk of cellular ATP and reactive oxygen species (ROS), serve as
calcium (Ca2+) stores, and play a central role in programmed cell death
[1]. They are surrounded by two biological membranes that delimit two
major aqueous subcompartments, the intermembrane space (IMS) and
the mitochondrial matrix. Mitochondria contain numerous copies of
their own DNA (mtDNA) that codes for a limited number of protein
products, almost exclusively subunits of the OXPHOS (oxidative
phosphorylation system) machinery and rRNA and tRNA components
of a speciﬁc mitochondrial translation apparatus. In mammals, 13
protein products are synthesized on mitochondrial ribosomes, all of
which are evolutionarily conserved hydrophobic OXPHOS subunits. The
mammalian OXPHOS machinery is composed of ﬁve multi-subunit
inner membrane-embedded enzyme complexes, the respiratory chain
and ATP synthase and is built up of more than 90 protein subunits
containing numerous prosthetic groups. Thus, the vast majority of thevarious ∼1500 mammalian mitochondrial proteins is encoded in the
nucleus, synthesized on cytoplasmic ribosomes and subsequently
sorted and imported into the mitochondria by means of a specialized
transport machinery [2–4].
Eukaryotic cytochrome c oxidase (CcO) is the terminal enzyme of
the mitochondrial electron transport chain. It is responsible for
electron transfer from soluble mobile carrier cytochrome c to
molecular oxygen as well as for proton translocation across the
inner membrane. Mammalian CcO is a hetero-oligomeric inner
membrane-embedded complex with a combined molecular weight
of 205 kDa and is composed of 13 structural subunits encoded by both
mitochondrial and nuclear genes. The core of the enzyme, which
incorporates all redox-active cofactors, is composed of three mito-
chondrially encoded subunits, Cox1, Cox2 and Cox3 that show high
evolutionary conservation. The remaining 10 evolutionarily younger
peripheral subunits that associate with the complex core are encoded
on nuclear DNA and synthesized in cytoplasm. They are required for
stability/protection of the enzyme core as well as for the regulation of
its activity. Besides the protein subunits, CcO contains several redox-
active prosthetic groups that are responsible for electron transfer and
dioxygen reduction. These include two copper centers (CuA and CuB)
located on subunits Cox2 and Cox1, respectively, and two heme a
moieties (heme a and heme a3) coordinated within the interior of
subunit Cox1 [5–7]. Either under mild detergent conditions or when
crystallized or reconstituted in phospholipid vesicles, the majority of
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with contacts between monomers mediated merely by subunits
Cox6a and Cox6b [8,9]. CcO dimerization likely plays a key structural–
functional role, conferring maximal structural stability for the
complex [10]. In addition to protein subunits and prosthetic groups,
crystalline preparations of bovine heart CcOwere shown to contain 13
lipids per enzyme dimer, with several of them likely important in O2-
transfer process or dimer stabilization [11].
The biogenesis of CcO is a complicated, sequential process that
requires coordinated expression of mitochondrial and nuclear genes,
mitochondrial import and membrane integration of subunit polypep-
tides, synthesis/import and incorporation of prosthetic groups, andﬁnal
assembly of matured subunits. A number of speciﬁc nuclear gene
products thatmediate the distinct functions required for CcObiogenesis
were identiﬁed. However, the correct biogenesis of the CcO complex
requires an even greater number of protein factors with much broader
substrate speciﬁcities. Indeed, accumulating evidence suggests that
mitochondrial ATP-dependent proteases, particularly the inner mem-
brane-bound FtsH/AAA family proteases and the soluble matrix
protease Lon, might also play an important role in this process. Besides
the well-established role of these proteolytic complexes in protein-
quality control, thesemultimeric assemblieswith additional chaperone-
like and translocase activities were shown to function in proteolytic
processing of regulatory proteins, degradation of native subunit
polypeptides and promotion of respiratory chain assembly.
2. CcO assembly factors
The vast majority of the over 30 gene products known to be
required exclusively for proper biogenesis of the eukaryotic CcO
complex have been identiﬁed through functional complementation
studies of respiratory-deﬁcient yeast mutants [12]. Subsequently, a
number of these so-called CcO assembly factors were shown to have
human homologues, while several of them have been studied at the
protein level [6]. These include copper metallochaperones Sco1, Sco2,
Cox11 and Cox17, which are involved in trafﬁcking/insertion of Cu(I/
II) ions into CuA and CuB copper centers in Cox2 and Cox1 subunits,
respectively; inner membrane proteins Cox10, Cox15 and Surf1,
which are required for synthesis or incorporation of heme a moieties
into Cox1; and Oxa1 and Cox18 translocases, which are involved in
the export/translocation of transmembrane segments of integral
inner membrane proteins, including CcO subunits. Although several
pathogenic mutations in each of the three mitochondrially encoded
CcO subunits [13] and one mutation in nuclear-encoded COX6B1
subunit [14] have been reported, the majority of fatal infantile CcO
deﬁciencies identiﬁed so far result from autosomal recessive muta-
tions in genes encoding CcO assembly factors. Indeed, two of the
human CcO assembly factors, LRPPRC and TACO1, both of which are
involved in mitochondrial CcO mRNA translation, were identiﬁed
primarily on the basis of their mutant phenotypes in human patients
using an integrative genomics approach or functional complementa-
tion, respectively [15,16].
2.1. LRPPRC and TACO1
Membrane-bound translational activator proteins that mediate
the membrane-recruitment of translating mitochondrial ribosomes
have been identiﬁed in yeast mitochondria [17,18]. They bind to 5′
untranslated leader sequences of mitochondrial transcripts and
physically interact with mitochondrial ribosome subunits [19–21].
The translational activators are mRNA-speciﬁc and, thus, regulate
mitochondrially encoded protein synthesis in a gene-speciﬁc manner.
This mechanism was not expected to be conserved in mammals
because mammalian mitochondrial mRNAs lack signiﬁcant 5′ un-
translated region (UTR) sequences, and themajority of genes involved
in translation of mitochondrially encoded proteins lack mammalianhomologues. The only exception was thought to be LRPPRC (leucine-
rich pentatricopeptide repeat cassette), the human homologue of
yeast Pet309. Pet309 is a mitochondrial translational activator that
binds speciﬁcally to the 5′ UTR of the COX1 mRNA. LRPPRC was
implicated in translation and stabilization of COX1 and COX3 mRNAs
[16,22]. Mutations in LRPPRC lead to French-Canadian form of CcO-
deﬁcient Leigh syndrome, which is characterized by a less severe
neurological involvement, including slower progression, when com-
pared to the classical Leigh syndrome clinical picture [16,22]. Both
Pet309 and LRPPRC contain several PPR motifs, consisting of
degenerated 35-amino acid sequences proposed to form two
antiparallel alpha helices [23]. These repeats characterize a large
protein family in plants with only a few examples found among fungi,
animals and protists. PPR proteins mostly participate in different steps
of sequence-speciﬁc RNAmetabolism [24]. Very recently, LRPPRC was
shown to interact with SLIRP (SRA-stem loop interacting RNA-binding
protein) as part of a high-molecular weight ribonucleoprotein
complex [25]. The disruption of this complex due to knockdown of
LRPPRC was shown to lead to reduction in steady-state levels of all
mitochondrial mRNAs. Based on these results LRPPRC was postulated
to act in posttranscriptional mitochondrial gene expression, being
involved in regulation of stability and handling of maturemRNAs [25].
Recently, a protein product of the gene CCDC44, subsequently
renamed as TACO1 (Translational Activator of COX I), was identiﬁed by
Shoubridge's group as a speciﬁc mammalianmitochondrial translation-
al activator [15]. Thematurepolypeptideof roughly 30 kDawas found in
the mitochondrial matrix as an oligomer or as part of a ∼74-kDa
complex. Loss of CCDC44/TACO1 results in late-onset Leigh syndrome
with CcO deﬁciency, very likely due to a speciﬁc defect in the synthesis
ofmitochondrially encoded subunit Cox1. The reduced amount of newly
synthesized Cox1 in TACO1 patient ﬁbroblasts is accompanied by com-
pensatory increase in some of the mitochondrially encoded subunits of
complex I and cytochrome b. The marked decrease in the level of fully
assembled CcO in TACO1-deﬁcient cells was not accompanied by
appearance of any of the previously identiﬁed subcomplexes, conﬁrm-
ing the role of Cox1as the initial seed for CcOassembly. Interestingly, the
inactivation of Saccharomyces cerevisiae TACO1 orthologue, YGR021w,
which exhibits 29% sequence identity, resulted in almost normal CcO
activity in cells grown on respiratory media [15].
2.2. Oxa1 and Cox18
Oxa1 belongs to the Alb3/Oxa1/YidC family of proteins, members
of which are involved in insertion of membrane proteins in
mitochondria, chloroplasts and bacteria. Oxa1 is an integral protein
of the inner mitochondrial membrane that facilitates the cotransla-
tional membrane integration of mitochondrial translation products as
well as the insertion of conservatively sorted nuclear gene products
into the inner membrane [26,27]. Oxa1 attains a Nout–Cin membrane
topology and possesses a hydrophobic core domain composed of ﬁve
transmembrane helices that ensures the membrane export of its
protein substrates [28,29]. Oxa1 proteins were not found in
unicellular eukaryotic parasites Giardia lamblia or Trichomonas
vaginalis that contain double-membranous mitochondria-like orga-
nelles devoid of respiratory complexes and organelle genome [30].
Several lines of evidence indicate that Oxa1 interacts with mitochon-
drial ribosome [31,32]. Unlike the bacterial Oxa1 homologue, YidC,
mitochondrial Oxa1 proteins contain a C-terminalα-helical domain of
roughly 100 residues that protrudes into the matrix [31,33]. This
domain is thought to mediate the interaction of Oxa1 with
mitochondrial ribosomal subunit Mrp20. This interaction is thought
to recruit the mitochondrial translation apparatus to the membrane-
embedded Oxa1 translocation complex [34]. Chemical crosslinking of
in organello-labeled mitochondrial translation products followed by
immunoprecipitation with anti-Oxa1 antibody has demonstrated that
Oxa1 interacts in a transient manner with nascent mitochondrially
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Cox3 [35]. Whereas the yeast Oxa1 represents a rather general export
machinery of the inner membrane, the membrane translocation of
both hydrophilic tails of Cox2 precursor is strictly contingent upon the
function of Oxa1 [36]. The other substrates of Oxa1, including Oxa1
itself, can be inserted independently of its function, albeit with
signiﬁcantly reduced efﬁciencies. The yeast Oxa1-null mutant is
respiratory-deﬁcient, has no detectable CcO activity and shows
markedly reduced levels of the cytochrome bc1 complex and F1FO-
ATP synthase [37,38]. Two distinct Oxa1 orthologues were identiﬁed
in Schizosaccharomyces pombe and both proteins can complement the
respiratory defect of yeast Oxa1-null cells [39]. Interestingly, the
double inactivation of these genes is lethal to this petite-negative
yeast. Depletion of Oxa1 in Neurospora crassa results in a slow-growth
phenotype accompanied by reduced subunit levels of CcO and NADH:
ubiquinone oxidoreductase (complex I). The N. crassa Oxa1 forms a
170–180-kDa homo-oligomeric complex, most likely containing four
Oxa1 monomers [40]. In Podospora anserina, Oxa1 appears to be
required for biogenesis of complex I and IV. Furthermore, decreased
production of ROS accompanied by increased lifespan was found in
P. anserina thermosensitive oxa1 mutant [41]. In addition to Oxa1,
mitochondria contain another homologous inner membrane protein,
Cox18, that deﬁnes the second Alb3/Oxa1/YidC subfamily. Because
deletion of COX18 in S. cerevisiae, Kluyveromyces lactis and S. pombe
leads to complete lack of cytochrome aa3 spectra and normal levels of
the remaining OXPHOS complexes, the function of Cox18 appears
conﬁned to CcO in lower eukaryotes [42–44]. In the absence of Cox18,
the steady-state levels of Cox2 are severely attenuated due to
increased degradation of the subunit [45,46]. The lack of Cox18 in
N. crassa results in partial reduction in cytochrome aa3 accompanied
by substantial induction of the alternative oxidase [47]. In contrast to
the transient interaction of Oxa1, the N. crassa Cox18 interacts with
Cox2 and Cox3 in a long-lived manner [47].
The human Oxa1 orthologue, referred to as Oxa1l, shares 33%
sequence identity with the corresponding yeast polypeptide [48]. The
human OXA1L cDNA was initially cloned by partial functional
complementation of the respiratory growth defect of the yeast
oxa1-79 mutant. It consists of an open reading frame (ORF) predicted
to encode a 435-amino acid protein [37]. The human OXA1L mRNA
was found to be enriched in mitochondria-bound polysomes from
HeLa cells, and the 3′ UTR of the OXA1L transcript was functionally
important when expressed in yeast cells [49]. We showed that human
OXA1L protein product is a mitochondrial integral membrane protein
that exists as part of a 600–700-kDa complex not appearing to contain
any of the OXPHOS complexes [50]. We further demonstrated that the
stable short hairpin RNA (shRNA)-mediated knockdown of human
Oxa1l in HEK293 cells leads to markedly decreased protein levels and
ATP hydrolytic activity of the F1FO-ATP synthase and moderately
reduced levels and activity of NADH:ubiquinone oxidoreductase
(complex I). This RNAi phenotype clearly suggests functional
involvement of the human protein in the assembly/stability of these
two OXPHOS complexes [50]. Similarly, yeast Oxa1 was shown to
mediate the assembly of the ATP synthase FO-subunit c into the
holoenzyme complex [51]. In sharp contrast to yeast oxa1mutant, the
assembly/stability of both CcO and the cytochrome bc1 complex
(complex III) was not negatively affected by knockdown of human
OXA1L. Indeed, up-regulated levels of CcO, in terms of both individual
subunits and holoenzyme complex, were found in these cells. In line
with this result, high-resolution respirometry revealed markedly
increased sodium azide-sensitive oxygen consumption of these cells.
2.3. Surf1
Surf1 is an integral protein of the inner mitochondrial membrane
required for the assembly of the CcO complex. The mature form of
human Surf1 has amolecularmass of∼30 kDa and is composed of twotransmembrane domains with a central loop region facing the IMS
[52]. Both transmembrane domains and the central loop are required
for proper insertion of the human protein into the inner membrane,
but the C-terminal tail of the protein is dispensable in this regard. In
contrast to the yeast homologue Shy1 [53], separately expressed N-
and C-terminal transmembrane domains of human Surf1 cannot form
a functional protein [52]. Although the precise molecular role of
human Surf1 in CcO biogenesis remains unknown, several lines of
evidence indicate that theprotein plays a role in someof theearly events
of CcO assembly, ranging from insertion of heme a/a3 into Cox1 to
promotion/stabilization of early subunits' assembly. Human cells
lacking Surf1 accumulate CcO subcomplexes composed of merely
Cox1, Cox4 and Cox5a, suggesting that the assembly is stalled at a
rather early stage [54,55]. Surf1 orthologues are found in terminal
oxidase operons of several prokaryote species in which the mature CcO
consists of only three core subunits that associate early in the assembly
process in eukaryotes [56,57]. Bacterial Surf1 orthologues have
repeatedly been implicated in the insertion and/or stabilization of
heme a/a3, which is thought to occur concurrently with or immediately
after membrane integration of Cox1 [58,59]. Because the yeast Surf1
homologue Shy1 was found in high-molecular weight CcO-containing
complexes, the protein is likely to have an additional role in some of the
late CcOassembly events aswell [60]. Recently itwasdemonstrated that
Shy1 associates with different inner membrane protein modules,
includingCcO subcomplexes aswell as supercomplex species composed
of partially and fully assembled forms of CcO and the cytochrome bc1
complex. The association of CcO subcomplexes with complex III was
observed even in the absence of the core subunit Cox2 [61]. Based on
these ﬁndings, Shy1, together with another yeast CcO assembly factor,
Cox14, was proposed to accompany transient forms of CcO, thereby
maintaining their competence for the incorporation of additional
subunits. This appears consistent with the ﬁnding that Cox13, the
yeast homologue of human Cox6a, is assembled after formation of
respiratory supercomplexes [62].
Yeast Shy1 genetically and/or physically interacts with several
factors involved in translational and early posttranslational steps of
Cox1 biogenesis. In S. cerevisiae, Cox1 synthesis is controlled by
translational activators Mss51 and Pet309. The high-copy expression
of Mss51, which has an additional role in posttranslational events of
Cox1 biogenesis, can suppress the CcO-deﬁcient phenotype of shy1Δ
cells. Mss51 and Cox1 form a transient complex that is stabilized by
Cox14. The accumulation of this complex is postulated to down-
regulate the translation of Cox1 under conditions of impaired CcO
assembly by sequestering Mss51 [46,61,63]. Shy1 is thought to
facilitate the release of Mss51 from the ternary complex, making it
available for Cox1 translation [64]. Recently, Coa1 and Coa2 were
identiﬁed as new yeast CcO assembly factors that act in early steps of
enzyme assembly [61,65,66]. Coa1 is an inner membrane-associated
protein that exists as part of the Mss51.Cox14.Cox1 ternary complex,
as well as in a complex with Shy1 alone. Coa1 may be involved in the
transition of newly synthesized Cox1 from the Mss51 complex to a
downstream intermediate involving Shy1 [65]. The respiration in both
coa1Δ and shy1Δ cells is enhanced by coexpression of Mss51 and
Cox10, suggesting that Coa1 may link heme a incorporation and
cotranslational insertion of Cox1. Coa2, which may possess a
chaperone function, appears to act downstream of Coa1, and probably
stabilizes Cox1 during the heme a3 insertion step [66]. This
stabilization may be accomplished by promoting Cox5a/Cox6
(human Cox4/Cox5a) association with Cox1, which may increase
the stability of the subunit by stabilizing the loops connecting the 12
transmembrane helices [66]. This is consistent with the fact that the
HAP4-induced upregulation of subunits Cox5 and Cox6 suppresses
the respiratory-deﬁcient phenotype of shy1 cells [67]. Several lines of
evidence indicate that Surf1/Shy1 may be responsible for the
insertion of heme a3 into Cox1. The Rhodobacter sphaeroides Surf1
homologue is required for the insertion/stabilization of heme a3
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Surf1-null mutant [58]. When coexpressed in E. coliwith enzymes for
heme a synthesis, the Paracoccus denitriﬁcans Surf1 homologues
Surf1q and Surf1c bind heme a in vivo and probably provide a protein-
bound heme a pool for the insertion into Cox1 [59]. cox11Δ cells are
peroxide sensitive, showing an almost 2-fold increase in protein
carbonylation, consistent with enhanced ROS production [68]. The
increased peroxide sensitivity of these cells stem from accumulation
of a transient pro-oxidant assembly intermediate composed of Cox1
with bound heme a3 moiety. Depletion of Shy1 in cox11Δ background
abrogates the peroxide sensitivity of these cells. Furthermore, shy1Δ
cells remain peroxide resistant even upon overexpression of Cox15,
known to markedly increase heme a levels in CcO assembly mutants.
The identity of the pro-oxidant heme is substantiated by the fact that
only heme a3 has an open coordination site that can catalyze
formation of the hydroxyl radical pro-oxidant when solvent-exposed
[68]. Mss51, Cox14, Coa1 and Coa2 are found exclusively in fungi,
lacking homologues in both higher eukaryotes and bacteria [64].
Furthermore, yeast Shy1 possesses additional C-terminal segments
that are not conserved in Surf1 proteins of other species. Thus, it is not
clear whether similar mechanisms mediated by functional homo-
logues of these proteins exist also in higher eukaryotes.
Zordan et al. have shown that ubiquitous posttranscriptional
silencing of SURF1 in Drosophila melanogaster is associated with 100%
egg-to-adult lethality, underdevelopment of the central nervous
system (CNS), particularly of the optic lobes, and impaired locomotor
behavior in larvae. The altered motor patterns were likely not due to
structural and/or functional abnormalities of muscle ﬁbers or
reduction in contractile efﬁciency; rather they probably resulted
from defective energy provision due to CcO deﬁciency. In contrast, a
pan-neuronal SURF1 knockdown led to slight impairment in locomo-
tor behavior and photoreactivity and strikingly increased longevity
when compared to controls. However, histological analysis failed to
reveal any marked neurodegeneration in the brains of these ﬂies [69].
In vertebrates, the SURF1 gene is part of the very tightly organized
and highly conserved surfeit gene cluster, which contains six house-
keeping genes (SURF1–6) that encodeboth structurally and functionally
unrelatedproteins [70]. The reason for the conservation of this structure
over 250 million years of divergent evolution between birds and
mammals remains obscure. Baden et al. reported that posttranscrip-
tional silencing of SURF1 in zebraﬁsh (Danio rerio) by morpholino
antisense oligonucleotides resulted in 50% reduction in CcO activity as
well as developmental defects in endodermal tissues, cardiac function
and swimming behavior. The hindbrain and neuronal tube exhibited
dramatically increased apoptosis and secondary motor neurons were
absent or abnormal. In contrast, the cardiac dysfunction was likely due
to impaired energy metabolism because the heart was devoid of
apoptotic cells, exhibiting increasingly poor performance over time [71].
The described phenotype of Surf1-deﬁcient zebraﬁsh was almost
identical to that of the COX5 knockdown animals, suggesting that the
described Surf1-deﬁcient phenotype can be readily attributed to
secondary CcO deﬁciency rather than to a speciﬁc lack of Surf1 protein
[71]. Two SURF1 knockout mouse models have been generated by the
Zeviani's group using either replacement of exons 5–7 by neomycin-
resistance (NEO)cassette [72]or insertionof a loxP sequence in exon7of
thegene [73]. Theprominent characteristic of the SURF1NEOKOmicewas
high embryonic lethality, which was subsequently attributed to
deleterious effects of the presence of the NEO cassette. In contrast,
SURF1loxP knockouts showed, in addition to mild CcO deﬁciency, altered
neuronal Ca2+ homeostasis, moderate functional and morphological
abnormalities in both skeletal muscle and liver, and substantially
prolonged lifespan [73]. In sharp contrast to severe CNS involvement of
human Surf1-deﬁcient patients, neither mouse SURF1 KO model
exhibited spontaneous neurodegeneration at any age. The positive
effects of murine SURF1 knockout on the lifespan of (−/−) animals is
strikingly similar to that of the D. melanogaster CNS-speciﬁc SURF1knockdown. On this account, it was suggested that the partial
suppression of respiratory chain activity may positively affect lifespan
of (−/−) animals, possibly also due to attenuated ROS production [56].
Consistent with these ﬁndings, CcO deﬁciency was associated with
reduced oxidative stress in CNS of COX10 knockout mice [74].
Mutations in SURF1, which account for the majority of nuclear-
encoded, isolated CcO deﬁciencies in humans, are characterized by the
development of Leigh syndrome, a subacute necrotizing encephalo-
myopathy [75]. The prominent pathology of Leigh syndrome is
represented by bilateral symmetric necrotic lesions in subcortical
areas of the brain (brain stem, basal ganglia and thalamus) that
consist of neuronal loss, demyelination and vascular proliferation
[76]. Most of the identiﬁed SURF1 mutations are predicted to lead to
loss of the protein. Human as well as yeast cells lacking Surf1/Shy1
retain approximately 10–20% of CcO activity, indicating that the
function of the protein is partially dispensable in both organisms [52].
In contrast to human Surf1, the lack of Shy1 leads to partially
pleiotropic effects including increased levels of cytochrome c and
elevated NADH-cytochrome c reductase activity [53]. Furthermore,
the human and yeast proteins fail to complement each other.
However, the proteins exhibit striking sequence similarity in some
conserved domains, and the elevated cytochrome c concentration and
increased complex III activity may reﬂect a yeast-speciﬁc compensa-
tory response [60]. Analogous to yeast, overexpression of NF-YA, the
catalytic subunit of the human homologue (NF-Y) of the yeast HAP
complex increases CcO activity of human SURF1 ﬁbroblasts. Unlike the
yeast HAP complex, the human NF-Y complex is not directly involved
in regulatingmitochondrial biogenesis, and themolecular mechanism
responsible for the suppression of the CcO defect in human SURF1
ﬁbroblasts is not known [67]. The severe CcO deﬁciency of SURF1
ﬁbroblasts is accompanied by barely detectable changes in cellular
respiratory rates under normoxic conditions [77]. Measuring CcO
oxygen kinetics by the partial oxygen pressure at half-maximal
respiration rate revealed markedly attenuated afﬁnity for oxygen of
the residual enzyme. This phenomenon could exacerbate the
respiratory defect in tissues where high energy demand meets up
with very low oxygen pressure, such as in the brain, a prominent
pathology site of Leigh syndrome SURF1 patients [78]. The fatal
neurological phenotype of CcO-deﬁcient Leigh syndrome is associated
with a remarkable tissue pattern of CcO assembly impairment,
pointing to a profoundly tissue-speciﬁc characteristic of CcO biogen-
esis [79]. Intriguingly, various tissue samples carrying mutations in
SURF1 exhibit, similar to SCO1 and SCO2 tissues, marked tissue-
dependent copper deﬁciency. This suggests that Surf1 is required in a
tissue-speciﬁc manner to maintain the cellular copper levels [55].
Interestingly, yeast cells lacking Shy1 are deﬁcient in mitochondrial
copper, whereas their total cellular copper content remains normal
[65]. Supplementation of shy1Δ cultures with exogenous copper
partially rescues the respiratory capacity of these cells [67].
2.4. Cox17
The small hydrophilic copper-binding protein Cox17 localizes in
yeast to both the cytoplasm and the mitochondrial IMS and was the
ﬁrst factor implicated in copper ion provision to CcO [80]. It delivers
Cu(I) to two downstream CcO copper-chaperones Sco1 and Cox11.
The interaction of Cox17 with Sco1 and Cox11 is thought to be
transient. Based on its dual localization, Cox17 was initially proposed
to act as a copper shuttle between the cytoplasm and the IMS [81].
Tethering Cox17 to the inner membrane by a heterologous trans-
membrane domain renders the protein fully functional, suggesting
that migration between the cytoplasm and IMS is not essential for its
function [82]. Deletion of COX17 in S. cerevisiae does not affect
mitochondrial copper content [83]. However, in vitro studies with
puriﬁed proteins and the yeast cytoplasm assay have demonstrated
that Cox17 can deliver Cu(I) to both Sco1 and Cox11 [84]. In addition
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conserved Cys residues upstream of the twin Cys motif. The protein is
functional without either of the two disulﬁdes in the twin Cx9C motif.
Two Cu(I) conformers of Cox17 were described so far. One is a
mononuclear Cu(I)–Cox17 monomer in the form of helical hairpin
that is stabilized by two disulﬁde bonds with Cys residues in the twin
Cx9C motif. The second Cu(I) conformer is an oligomeric protein
complex containing reduced thiolates that is capable of binding a
polycopper–thiolate cluster. Purifying Cox17 from yeast IMS yields a
protein devoid of bound copper [80].
Knockout of COX17 in mice leads to lethality of (−/−) individuals
between embryonic days E8.5 and E10, conﬁrming the essential
character of Cox17 [85]. The human Cox17 orthologue has been
identiﬁed that shares 48% sequence identity with yeast counterpart
[86]. Overexpression of the human Cox17 rescues the CcO activity
defect of human SCO2 but not SCO1-deﬁcient cells [87]. HeLa cells in
which the expression of Cox17 was downregulated by the use of
siRNA showed diminished levels of CcO and CcO-containing super-
complexes [88]. The accumulation of a 158-kDa Cox1-containing
subcomplex in these cells that was devoid of Cox2 suggested a role for
human Cox17 in the maturation of Cox2 but not Cox1.
2.5. Sco1 and Sco2
Human Sco1 and Sco2 are closely related inner mitochondrial
membrane copper-binding proteins encoded by paralogous genes.
They exert nonoverlapping, cooperative roles in copper delivery to
CcO [87]. In addition, they are involved in the maintenance of cellular
copper homeostasis, presumably by controlling cellular copper export
[89,90]. Very recently, human SCO proteins were reported to carry out
distinct, stage-speciﬁc roles during Cox2 synthesis and CuA site
maturation [91]. Interestingly, the tumor suppressor p53 directly
regulates mitochondrial respiration through transactivation of human
SCO2 transcription [92]. Mutations in both SCO1 and SCO2 cause
severe tissue-speciﬁc CcO assembly impairment accompanied by
marked cellular copper deﬁciency [55,79,90,93,94]. However, both
genes are ubiquitously expressed and display a similar expression
pattern across human tissues. SCO1 mutations have originally been
reported in only a single pedigree, where the two patients, presenting
with fatal infantile encephalomyopathy and hepatopathy, were
compound heterozygotes carrying a nonsense mutation on one allele
and a P174Lmissensemutation on the second allele [94]. Recently, we
have studied the consequences of a novel homozygous SCO1missense
mutation (G132S) found in a patient with CcO deﬁciency associated
with early onset hypertrophic cardiomyopathy, hypotonia, encepha-
lopathy and hepatopathy [55]. Thus, the lack of an apparent cardiac
involvement in the previously published SCO1 cases, which was in
sharp contrast to SCO2mutations, very likely resulted either from the
considerably reduced survival time of both siblings or the distinct
nature of the missense allele expressed in these patients. Indeed, the
P174L mutant Sco1 exhibits markedly altered functional properties
and almost normal polypeptide levels [95], whereas the G132S allele
appears to lead to a simple, yet almost complete loss of protein and
function [55]. In contrast to SCO1, SCO2mutations are more common,
with the vast majority of reported patients carrying at least one E140K
missense allele [96,97]. SCO2mutations cause fatal infantile encepha-
lomyopathy and hypertrophic cardiomyopathy. SCO2 patients homo-
zygous for the E140K substitution have a delayed onset and slightly
prolonged course of the disease compared with compound hetero-
zygotes [96]. Recently,Winge's group demonstrated that yeast cox11Δ
cells accumulate a CcO subcomplex composed merely of Cox1 subunit
with bound heme a3 that exhibitsmarked pro-oxidant properties [68].
Indeed, besides the CcO holoenzyme defect, mitochondria of clinically
affected tissues harboring SCO2 mutations are characterized by
markedly increased levels of Cox1-containing subcomplexes with
apparent molecular weight corresponding with that of free Cox1subunit [79]. Thus, it appears plausible that increased ROS production
may, in addition to energy deprivation, represent another factor
responsible for the severe clinical involvement of SCO2 tissues with
profound CcO assembly defect.
SCOproteins are integral innermembrane components consisting of
a globular copper-binding domain that protrudes into the IMS [98]. This
domain exhibits a thioredoxin fold composed of a central four-stranded
β sheet surrounded by four α helices [99]. A single Cu(I) binding site is
formed by cysteinyl residues of the Cx3C motif and a histidyl residue
found within the globular domain. The structures of the metal-free
human Sco1 conformer and Cu1Sco1 complex are similar with only one
loop showing signiﬁcant rearrangements [100]. Sco1 and Sco2 are
tethered to the innermembrane by a single N-terminal transmembrane
helix that was shown to be functionally important in Sco1 [101]. The
human Sco2 conformer resembles human Sco1 with the exception of
exhibiting greater conformational dynamics [102]. SCO proteins are
thought to act downstream of Cox17 in the copper delivery pathway to
CuA site in Cox2. Sco1 is copper-metallated by Cox17 in vitro. It is not
known whether Sco1 delivers both Cu(I) and Cu(II) ions to build the
binuclear, mixed valent CuA center in Cox2. Consistent with the
composition of CuA center, SCO proteins can bind either Cu(I) or Cu
(II) ions [103]. SCO proteinsmay form a complex in order to deliver two
copper ions to Cox2 simultaneously [87]. The involvement of human
SCO proteins in copper delivery to CcO is further supported by the fact
that the missense mutations in human SCO1 (P174L) and SCO2 (E140K
and S240F) are located in the vicinity of the conserved Cx3C copper-
binding motif [94,104]. Additionally, the CcO defect of both SCO1 and
SCO2ﬁbroblasts andmyoblasts is at least partially rescuedbyexogenous
copper supplementation [87,93]. Finally, overexpressing of human SCO
proteins with conserved cysteinyl and histidyl residues substituted by
alanines fails to rescue the CcO deﬁciency of either SCO1 or SCO2
ﬁbroblasts [103].
Yeast cells lacking Sco1 are devoid of CcO activity and show
markedly diminished levels of Cox2. Although yeast also encodes a
Sco2 protein that is capable of binding copper ions [105], this protein
has no apparent function in CcO assembly [106]. When over-
expressed, both yeast Sco1 and Sco2 were shown to physically
interacted with Cox2 [107]. Recently, using immunoprecipitation and
two-dimensional western blotting, we have demonstrated that
human Sco1 physically interacts with the fully assembled CcO
complex in both skeletal muscle and HEK293 cell mitochondria [55].
Originally, based on sequence similarity of Sco1 with the peroxir-
edoxin protein family, the protein was proposed to be involved in the
maintenance of CuA site cysteines in reduced state [108]. Furthermore,
on the basis of high-resolution structural data, human Sco1 has been
implicated to function as a redox switch in the IMS [99].
We have shown that human Sco2 acts in a highly tissue-speciﬁc
manner at an early stage of CcO assembly, very likely during the
maturation of Cox2 subunit [79]. Furthermore, we demonstrated that
the E140K substitution leads to severely diminished Sco2 levels in a
patient heart, liver, brain and ﬁbroblasts, suggesting severely
impaired stability of the mutant protein. Based on the fact that this
amino acid substitution slightly perturbed copper-binding of Sco2, it
was speculated that the stability of Sco2 may depend on it being
copper-loaded [91]. The previously identiﬁed SCO1 and SCO2
missense mutations are located near the conserved copper-binding
motif, suggesting that the loss-of-function outcome may relate to
perturbed copper-binding of the protein. However, SCO2 missense
mutations are associated with severely impaired stability of the
protein, and the E140K mutant retains rather appreciable residual Cu
(I)-binding properties [109]. Importantly, overexpressing the E140K
mutant Sco2 in the corresponding mutant background led to rescue of
the CcO defect [90]. In contrast, the P174Lmutation does not affect the
ability of Sco1 to bind and retain copper ions; however, its ability to be
copper-loaded by Cox17 is severely compromised [95]. Based on the
inability to detect the residual G132Smutant Sco1 in the dimeric form
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protein region previously shown to be required for dimerization, we
have proposed that dimerization is required to stabilize Sco1.
Whereas the G132S Sco1 skeletal muscle mitochondria accumulated
two Cox2-containing subcomplexes, the corresponding Sco2-deﬁ-
cient samples are characterized by a complete absence of such species.
This result suggests that Sco1 is very likely responsible for a different
posttranslational aspect of Cox2 biogenesis than Sco2 [55]. This
conclusion is further supported by the fact that the steady-state level
of Sco2 was virtually unaffected in the Sco1-deﬁcient background.
Recently, Leary et al. have reported that Cox2 synthesis is diminished
in human SCO2 but not SCO1 cells [91]. The authors concluded that
Sco2 is required for the synthesis of Cox2 in a manner that depends on
its ability to bind copper, and that it acts upstream of Sco1 during the
biogenesis of Cox2 [91]. It was further demonstrated that a fraction of
total Sco2 acts as a thiol-disulﬁde oxidoreductase, oxidizing the copper-
coordinating cysteines in Sco1 during Cox2 maturation [91]. Under
physiological conditions, the cysteines in the Cx3Cmotif of Sco1 exist as
amixedpopulation of oxidizeddisulﬁdes and reduced thiols. In contrast,
Sco1 molecules from either SCO background exhibited altered ratio of
oxidized to reduced cysteines. This ratio was shifted towards disulﬁdes
upon overexpression of wild-type Sco2 and towards thiols upon
knockdown of mutant Sco2 in the SCO2 background [91].
Leary et al. showed that tissues and/or ﬁbroblasts cultures
harboring mutations in SCO1, SCO2, COX10 or COX15 exhibit marked
copper-deﬁcient phenotype, consistent with the involvement of the
corresponding gene products in cellular copper homeostasis [90].
Importantly, the copper deﬁciency phenotypes of SCO1, SCO2 and
COX15 mutant ﬁbroblasts were fully dissociable from the respective
CcO defects. Kinetic labeling studies using 64Cu indicated that the
copper defect of SCO1 and SCO2 patient ﬁbroblasts is caused by a
defect in cellular copper retention rather than copper uptake.
Recently, we have demonstrated that tissues harboring mutations in
SURF1 exhibit marked tissue-dependent copper deﬁciency, further
expanding the list of CcO assembly factors with possible roles in the
maintenance of cellular copper homeostasis [55]. The observed
association of human Sco1 with the fully assembled CcO prompted
us to hypothesize that the regulation of cellular copper homeostasis
may involve CcO as an important cellular copper recipient [55]. Very
recently, Schon's group generated SCO2 knockout as well as SCO2
E140K knock-in mouse models. Whereas the both surviving mice
models, homozygous knock-in mice and knock-in/knockout hetero-
zygotes, recapitulate many of the characteristics of human SCO2
deﬁciency, they present with only very mild CcO defect. Indeed, they
have normal tissue copper levels, with only mitochondrial copper
content being signiﬁcantly reduced [110].
3. Involvement of ATP-dependent proteases
A number of more or less speciﬁc proteases, including processing
peptidases, ATP-dependent proteases and oligopeptidases, are found
within the various subcompartments of mitochondria that mediate
the selective proteolysis of mitochondrial proteins. Two soluble ATP-
dependent proteases, the Lon protease and the ClpXP protease, are
found within the mitochondrial matrix. In addition, two ATP-
dependent proteolytic complexes, them- and i-AAAmetalloproteases,
are anchored within the inner mitochondrial membrane, exposing
their catalytic domains to the opposite membrane surfaces [111].
Three out of these four identiﬁed proteolytic complexes were shown
to be involved in degradation of unassembled CcO subunits.
Mitochondrial ATP-dependent proteases belong to the AAA+ family
of proteins (ATPases Associated with a variety of cellular Activities),
which is characterized by the presence of a conserved P-loop ATPase
module [112]. They assemble into multimeric protein complexes with
a central proteolytic chamber and, in addition to proteolytic function,
exhibit chaperone-like and translocase activities [113]. They areimplicated in the surveillance of protein-quality control allowing for
the selective degradation of unassembled and damaged proteins
within the various mitochondrial subcompartments [111,114,115]. In
contrast tomostmammalian cellular proteins that exhibit half-lives of
up to several hours [116], the majority of mitochondrial proteins are
quite stable, with half-lives of several days [117–119]. Indeed, the
half-life of the CcO complex was estimated to be about three days
[120]. However, if severely damaged, mitochondria can be removed
by a non-selective process, so-called mitochondrial autophagy
(mitophagy) [121,122].
Lon is a homo-oligomeric complex with serine protease activity that
forms soluble heptameric ring-shaped assemblieswithin themitochon-
drial matrix [114]. It has been shown to recognize, unfold and degrade
misfolded, unassembled and oxidatively damaged matrix proteins
thereby preventing their deleterious accumulation [123]. Among the
several identiﬁed endogenous substrates of mammalian Lon are the
nuclear-encoded CcO subunits Cox4 and Cox5a (Fig. 1) [114].
Furthermore, overexpression of both wild-type and proteolytically
inactive Lon in cells under ER stress was suggested to promote the
assembly of subunit Cox2 into Cox1-containing complexes [124].
Subunit Cox4 is thought to associate with the membrane-embedded
subunit Cox1 at the very beginning of CcO assembly [125,126]. Its
association with Cox1 is thought to occur in the form of a Cox4·Cox5a
heterodimer [79]. The unassembled Cox4 appears relatively stable, as
substantial levels of the free subunit are found within mitochondria
under various conditions. On the other hand, excess levels lead to its
rapid proteolytic degradation [126]. Cox4 contains a single transmem-
brane helix and, when assembled, exposes a large soluble N-terminal
domain into the mitochondrial matrix [8]. In mammals, subunit Cox4
exists as two isoforms; Cox4-1 and Cox4-2 expressed ubiquitously and
at high levels in the lungs and trachea, respectively [127]. Expression of
Cox4 isoforms was shown to be regulated by oxygen availability in
mammalian cells [127]. This regulatory circuit involves HIF-1α, an O2-
regulated subunit of hypoxia-inducible factor 1 (HIF-1), and the Lon
protease. HIF-1 is a transcriptional activator that plays a key role in
regulating oxygen homeostasis in metazoan species [128]. Under
aerobic conditions, the O2-regulated HIF-1α subunit is prolyl hydrox-
ylated, and targeted to ubiquitination and proteasomal degradation
[129,130]. Under hypoxic conditions, the α-subunit accumulates, and
HIF-1 eventually triggers the transcriptional upregulation of both COX4-
2 isoform and LON. Lon very likely mediates the degradation of Cox4-1
and may also facilitate the assembly of newly imported Cox4-2 into the
CcO complex (Fig. 1) [114,127].
m-AAA protease complex is one of the two homologous FtsH/AAA
family membrane-bound ATP-dependent proteases found within the
inner mitochondrial membrane [115]. Subunits of AAA proteases
contain the highly conservedWalker A (P-loop) andWalker B ATPase
modules within their AAA domains. The energy derived from ATP
hydrolysis is utilized to unfold substrate proteins and transport them
into the internal proteolytic cavity [131]. The mitochondrial AAA
proteases recognize misfolded, solvent-exposed domains of substrate
proteins, short terminal protein tails projecting from the membrane
bilayer, and accessible interhelical loops of polytopic transmembrane
proteins [111,115,132].m-AAA protease is active on the matrix side of
the inner membrane and exists in human mitochondria as two
isoenzyme complexes build up of Spg7 and/or Afg3l2 subunits [133].
The yeast m-AAA complex is implicated in the degradation of
unassembled mitochondrially encoded CcO subunit Cox3 (Fig. 1)
[134,135]. Cox3 is a highly hydrophobic subunit of the CcO core
spanning the inner membrane with seven transmembrane helices. In
contrast to the remaining two mitochondrially encoded CcO subunits,
Cox3 does not contain any prosthetic groups and is not directly
involved in catalysis [8]. Although a long loop between helices III and
IV of the subunit is exposed into the IMS, it is likely the soluble N-
terminus protruding into the matrix that is recognized by the m-AAA
protease. Subunit Cox3 is thought to have an important role in CcO
Fig. 1.Mitochondrial ATP-dependent proteases and their cytochrome c oxidase (CcO) subunit substrates. Schematic representation of energy-dependent protease complexes found
in humanmitochondria and their known and putative CcO subunit substrates. Whereas the membrane-bound FtsH/AAA family proteases (m- and i-AAA protease) act on either side
of the inner membrane (IM), the soluble Lon and ClpXP complexes function within the mitochondrial matrix. Of the two identiﬁed humanm-AAA protease isoenzymes, the hetero-
oligomeric paraplegin/Afg3l2 complex is depicted. The role of i-AAA protease in degradation and folding of unassembled Cox2, as well as the involvement of m-AAA protease in
degradation of unassembled Cox3, is extrapolated from ﬁndings in yeast. The solid arrows represent proteolysis and the dashed arrows denote folding/assembly effects. (IMS,
intermembrane space). See text for references.
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intermediate, which occurs immediately after addition of subunit
Cox2, is believed to trigger the cascade-like association of most of the
remaining nuclear-encoded CcO subunits [6]. Very recently, the
expression in yeast cells of the mutant human AFG3L2 derived from
patients with autosomal dominant spinocerebellar ataxia (SCA) type
28 was shown to result in severe (≥90%) reduction in both CcO
activity and protein levels [136]. Since the activity of respiratory
complexes III and V was only moderately affected in these cells, it
appears likely that the impaired assembly of mitochondrial ribosome
due to defective processing of the mitochondrial ribosomal protein
MrpL32 is not the only mechanism responsible for the observed CcO
defect.
The yeast i-AAA protease is an inner membrane-anchored homo-
oligomeric complex build up of Yme1 (Yeast mitochondrial escape 1)
subunits. In contrast to m-AAA protease subunits, Yme1 is tethered to
the membrane by a single N-terminal transmembrane helix and
exposes its catalytic domain into the IMS [111]. The yeast i-AAA
complex has a combined molecular weight of 800–1000 kDa and
consists of additional adaptor proteinsMgr1p andMgr3p [137]. Yeast i-
AAA protease conducts protease, chaperone-like and possibly also
translocase functions on the IMS face of the inner membrane
[132,138,139]. So far, only a few endogenous quality control substrates
of the yeast i-AAA complex have been identiﬁed. They include
unassembled inner membrane proteins prohibitin 1 and 2 (Phb1 and
Phb2), the soluble yeast NADH dehydrogenase Nde1, and importantly,
also the unassembled CcO subunit Cox2 (Fig. 1) [140–142]. The levels of
unassembled Cox2 are very low in both yeast and humanmitochondria
due to rapid proteolytic turnover of the free subunit [79,142]. This
situation is in sharp contrast to another subunit of the CcO core Cox1,
which is highly stable in the unassembled state being sequestered in
several non-subunit complexes [79,124,143]. Initially, itwas shown that
the degradation of unassembled Cox2 can be at least partially prevented
by deletion of YME1 [142]. On the other hand, steady-state levels of
Cox2 are not affected in yeast yme1Δ cells [137]. This observation
suggests that the i-AAA complex is not the only protease responsible for
degradation of unassembled Cox2 in yeast. Cox2 is the smallest and the
least hydrophobic subunit of the CcO core, coordinating the binuclear
CuA center and constituting the docking site for cytochrome c [6]. Itconsists of a large polar C-terminal domain that protrudes into the IMS
and a transmembraneα-helical hairpin that anchors the subunit within
the membrane bilayer [8]. The fully exposed C-terminal domain of the
unassembledmembrane-embedded subunit is the likely target of the i-
AAA complex.When assembled, Cox2 exhibits relatively high resistance
to trypsin or proteinase K, as it is protected by peripherally associated
nuclear-encoded subunits [30]. Interestingly, when the export of the C-
terminal domain of yeast Cox2 precursor is prevented by deletion of
Mss2, the unassembled precursor is instead subject to degradation by
the m-AAA protease [144]. Cox2 has a key role in CcO assembly and
function, and several protein factors are known to be involved in its
maturation [6]. Therefore, besides the protection against possible
deleterious effects of excess Cox2 levels that may involve increased
ROS production, the tight proteolytic control of free Cox2 in both yeast
andmammals likely serves as one of the control points in CcO assembly.
Recently, Fiumera et al. demonstrated that in the absence of its adaptor
subunits Mgr1 and Mgr3, the yeast i-AAA complex acts as a chaperone
promoting the folding and/or assembly of the C-terminus of Cox2 that
was aberrantly translocated by the excess of Oxa1 (Fig. 1) [30]. Indeed,
this is theﬁrst report of Yme1being involved in theproductive foldingof
mitochondrial proteins in vivo.
4. Concluding remarks
The combined efforts of researchers working on yeast, bacterial
and mammalian systems underlie the recent progress in the
understanding of the various mechanisms involved in eukaryotic
CcO biogenesis. In particular, a major advance has been made in
structural–functional characterization of proteins that ensure the
delivery and insertion of copper ions to CcO. Consequently, an
unexpected mechanistic link between mitochondrial and cellular
copper metabolism has emerged that involves at least the CcO-
speciﬁc SCOmetallochaperones. In contrast, the molecular function of
Surf1 still remains to be clariﬁed, though solid evidence from studies
on bacterial as well as yeast systems exists in support of a role for the
protein in heme a provision/insertion to Cox1. Novel levels of
regulation of CcO biogenesis were uncovered in S. cerevisiae, among
them negative regulation of Cox1 translation by the availability of its
assembly partners, as well as the requirement for CcO biogenesis of
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mammalian Cox1-speciﬁc translational activator suggests the existence
of an unexpected regulatory level of mammalian mitochondrial gene
expression. Finally, results of recent work on components of mitochon-
drial protein-quality control system suggests that, besides their
proteolytic protein-quality control function and involvement in protein
processing, mitochondrial ATP-dependent proteases may facilitate the
productive folding and assembly of proteins, including CcO subunits.
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